Edap Tms (NASDAQ:EDAP) Now Covered by Analysts at StockNews.com

StockNews.com started coverage on shares of Edap Tms (NASDAQ:EDAP) in a research report report published on Sunday morning. The firm issued a hold rating on the medical equipment provider’s stock.

A number of other brokerages also recently issued reports on EDAP. Piper Sandler lowered their price target on shares of Edap Tms from $5.00 to $4.50 and set an “overweight” rating on the stock in a report on Friday, March 28th. Jefferies Financial Group reiterated a “hold” rating and issued a $2.00 target price (down from $8.00) on shares of Edap Tms in a research note on Friday, April 4th. Finally, HC Wainwright restated a “buy” rating and set a $19.00 price target on shares of Edap Tms in a research report on Friday, March 28th.

Edap Tms Trading Down 1.4 %

Shares of EDAP opened at $1.36 on Friday. The business has a 50-day moving average of $2.22 and a 200 day moving average of $2.36. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.46 and a current ratio of 2.18. Edap Tms has a fifty-two week low of $1.26 and a fifty-two week high of $7.73. The firm has a market cap of $50.46 million, a P/E ratio of -2.09 and a beta of 0.12.

Edap Tms (NASDAQ:EDAP) last announced its quarterly earnings results on Thursday, March 27th. The medical equipment provider reported ($0.05) earnings per share for the quarter, beating the consensus estimate of ($0.11) by $0.06. The company had revenue of $22.69 million during the quarter, compared to analysts’ expectations of $20.83 million. Edap Tms had a negative return on equity of 44.21% and a negative net margin of 34.92%. As a group, research analysts forecast that Edap Tms will post -0.6 EPS for the current year.

Institutional Investors Weigh In On Edap Tms

Institutional investors and hedge funds have recently bought and sold shares of the stock. Illumine Investment Management LLC bought a new position in shares of Edap Tms in the 4th quarter worth $50,000. BNP Paribas Financial Markets grew its position in Edap Tms by 23.7% in the third quarter. BNP Paribas Financial Markets now owns 23,000 shares of the medical equipment provider’s stock worth $59,000 after acquiring an additional 4,400 shares in the last quarter. Millennium Management LLC increased its stake in Edap Tms by 218.5% in the fourth quarter. Millennium Management LLC now owns 48,915 shares of the medical equipment provider’s stock valued at $108,000 after acquiring an additional 33,558 shares during the last quarter. Jane Street Group LLC raised its position in Edap Tms by 174.7% during the fourth quarter. Jane Street Group LLC now owns 31,361 shares of the medical equipment provider’s stock valued at $69,000 after purchasing an additional 73,361 shares in the last quarter. Finally, Schonfeld Strategic Advisors LLC lifted its stake in Edap Tms by 48.5% during the fourth quarter. Schonfeld Strategic Advisors LLC now owns 160,800 shares of the medical equipment provider’s stock worth $355,000 after purchasing an additional 52,500 shares during the last quarter. 62.74% of the stock is owned by hedge funds and other institutional investors.

Edap Tms Company Profile

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.